Skip to main content

CORRECTION article

Front. Oncol., 29 September 2022
Sec. Cancer Imaging and Image-directed Interventions
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1040637

Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice

This article is a correction to:

  1. Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice

    1. Read original article
Diana Yuzhakova*&#x;Diana Yuzhakova1*†Elena Kiseleva&#x;Elena Kiseleva1†Marina ShirmanovaMarina Shirmanova1Vladislav Shcheslavskiy,*Vladislav Shcheslavskiy1,2*Daria Sachkova,Daria Sachkova1,3Ludmila SnopovaLudmila Snopova1Evgeniya BederinaEvgeniya Bederina1Maria Lukina,Maria Lukina1,4Varvara DudenkovaVarvara Dudenkova1Gaukhar Yusubalieva,Gaukhar Yusubalieva5,6Tatyana BelovezhetsTatyana Belovezhets7Daria MatvienkoDaria Matvienko7Vladimir Baklaushev,Vladimir Baklaushev5,6
  • 1Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Nizhny Novgorod, Russia
  • 2R&D Department, Becker&Hickl GmbH, Berlin, Germany
  • 3Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia
  • 4Laboratory of Molecular Oncology, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia
  • 5Biomedical Research Center, Federal Research and Clinical Center, Federal Medical and Biological Agency, Moscow, Russia
  • 6Laboratory of Molecular Mechanisms of Regeneration and Aging, Engelhardt Institute of Molecular Biology, Moscow, Russia
  • 7Department of Molecular Immunology, Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russia

A corrigendum on
Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice

by Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D and Baklaushev V (2022). 12:897839. doi: 10.3389/fonc.2022.897839

In the published article, there was an error in the order for Figure 7 and Figure 8 as published. The images from Figure 7 and Figure 8 were interchanged, while the Figure legends were in the right places. The corrected Figure 7 and Figure 8 appear below.

FIGURE 7
www.frontiersin.org

Figure 7 Macro-FLIM of human GBM xenografts and normal brain. (A) Representative autofluorescence time-resolved images of GBM7-Luc2-mKate2 xenografts, U87 MG xenograft and normal mouse brain without tumor. Enlarged regions with a tumor are indicated by the black squares on the lower-magnification panel. Corresponding H&E stained section is presented under each enlarged region. (B) Quantification of the mean fluorescence lifetime tm in NAD(P)H spectral channel in (1) dual-labeled human GBM xenografts and (2) U87 MG xenografts and normal brain. Scatter dot plot displays the measurements for individual animals (dots) and the mean and SEM (horizontal lines). WM is a white matter.

FIGURE 8
www.frontiersin.org

Figure 8 Wide-field OCT color-coded maps of the mouse brain with GBM7-Luc2-mKate2 tumor (A, B) and corresponding histology (C). Color-coded maps based on two optical coefficients calculation: attenuation in co-channel (Attco-) (A) and in cross-channel (Attcross-) (B). Perifocal areas of high cancer density are marked with arrows (see enlarged fragments). T, tumor; C, cortex; WM, white matter.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: glioblastoma (GBM), primary cell line, patient-derived xenograft (PDX), fluorescence imaging, FLIM (fluorescence lifetime imaging microscopy)

Citation: Yuzhakova D, Kiseleva E, Shirmanova M, Shcheslavskiy V, Sachkova D, Snopova L, Bederina E, Lukina M, Dudenkova V, Yusubalieva G, Belovezhets T, Matvienko D and Baklaushev V (2022) Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice. Front. Oncol. 12:1040637. doi: 10.3389/fonc.2022.1040637

Received: 09 September 2022; Accepted: 15 September 2022;
Published: 29 September 2022.

Edited and Reviewed by:

Ellen Ackerstaff, Memorial Sloan Kettering Cancer Center, United States

Copyright © 2022 Yuzhakova, Kiseleva, Shirmanova, Shcheslavskiy, Sachkova, Snopova, Bederina, Lukina, Dudenkova, Yusubalieva, Belovezhets, Matvienko and Baklaushev. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Diana Yuzhakova, yuzhakova-diana@mail.ru; Vladislav Shcheslavskiy, vis@becker-hickl.de

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.